Takeda Pharmaceutical Company Limited has resolved to dispose of 524,400 treasury shares at 186 yen as part of its restricted stock award program, raising 97,538,400 yen. The disposal is scheduled for August 14, 2026.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"5244","jir_company_name":"Takeda Pharmaceutical Company Limited","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-07-16","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/07\/5244-20260716-01.pdf","jir_short_summary":"Takeda Pharmaceutical Company Limited has resolved to dispose of 524,400 treasury shares at 186 yen as part of its restricted stock award program, raising 97,538,400 yen. The disposal is scheduled for August 14, 2026.","jir_summary":"### Overview of the Disposal\nTakeda Pharmaceutical Company Limited has resolved at the Board of Directors meeting to dispose of 524,400 treasury shares at 186 yen on August 14, 2026. This disposal is part of the restricted stock award system, generating proceeds of 97,538,400 yen. The disposed shares will be allocated to directors and employees, with restrictions on transfer or pledge rights. The purpose of the disposal is to enhance motivation to contribute to stock price appreciation and corporate value improvement as part of its compensation scheme.\n\n### Impact on Shareholders and Future Outlook\nSince this share buyback does not involve issuance of new shares, the direct dilution effect on shareholders is considered limited. The funds raised will likely be used for future business investments and growth strategies. The disposal is scheduled for August 14, 2026, and shareholders and investors should pay attention to the company\u2019s future stock price trends and growth strategies.","jir_financial_highlights":"Number of Shares Disposed: 524,400 shares (unknown)\nDisposal Amount: 97,538,400 yen (unknown)\nDisposal Price per Share: 186 yen (unknown)","jir_category":"","jir_hashtags":"#TakedaPharmaceutical, #ShareBuyback, #JapaneseStocks","jir_key_figures":"Number of Shares Disposed: 524,400 shares\nDisposal Amount: 97,538,400 yen\nDisposal Price per Share: 186 yen","jir_meta_title":"\u3010Takeda Pharmaceutical Company Limited\u3011Share Buyback of 524,400 Shares | Scheduled for August 14, 2026","jir_meta_description":"Takeda Pharmaceutical Company Limited will dispose of 524,400 treasury shares at 186 yen as part of its restricted stock award system, raising 97,538,400 yen. Scheduled for August 14, 2026.","jir_og_title":"\u3010Takeda Pharmaceutical Company Limited\u3011Share Buyback | Scheduled for August 14, 2026","jir_og_description":"Takeda Pharmaceutical Company Limited will dispose of 524,400 treasury shares at 186 yen, raising 97,538,400 yen. Shareholders and investors should monitor future developments.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":59141,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"share_cancellation","footnotes":""},"sector":[],"importance":[],"class_list":["post-81842","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n